Finding risk factors in left ventricular non-compaction
Part of Heart & circulation clinical trials.
This study looks at people with left ventricular non-compaction (a condition where the heart muscle is spongy) to find what factors might predict their health risks. By joining, you'll help doctors better understand and care for others with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of left ventricular non-compaction (LVNC).
- You must be 18 years of age or older.
- If you are in the retrospective group, your diagnosis must have been made between 2010 and 2020.
- You cannot have any other type of cardiomyopathy (heart muscle disease) that is linked to a genetic mutation you have.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at different types of heart muscle diseases that are not caused by blocked arteries (non-ischemic cardiomyopathies). It aims to better understand how to diagnose, predict outcomes, and treat these conditions by gathering information from many patients over time.
This study looks at people with a rare heart muscle condition called non-compaction cardiomyopathy. The goal is to better understand risks and find ways to prevent problems early.
This registry study collects information, blood samples, and MRI images from people with non-ischemic cardiomyopathy (a heart muscle disease not caused by blocked arteries). By joining, you help researchers better understand the condition and find new ways to diagnose and treat it.
This study uses heart MRI scans to predict who might develop dangerous heart rhythms. It's for people with certain types of non-ischemic heart disease who have already had an MRI with contrast.
This trial tests an experimental drug called NVC-001 for people with a specific genetic heart condition (LMNA-related dilated cardiomyopathy) that causes the heart to become weak and enlarged. The goal is to see if the drug can help improve heart function.
This study looks at people with unusual or rare heart problems, or people with a family history of these issues. Doctors and researchers may collect and study your blood or tissue (and possibly store samples) to learn what causes the condition and how it may affect the heart.
Hear when a new Left Ventricular Noncompaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.